Literature DB >> 11581065

Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.

A N Chao1, C L Shields, H Krema, J A Shields.   

Abstract

PURPOSE: To evaluate the clinical findings, histopathologic features, methods of management, and outcomes in 25 patients with eyelid sebaceous gland carcinoma with and without conjunctival intraepithelial (pagetoid) invasion. PARTICIPANTS: Twenty-five patients with sebaceous gland carcinoma of the periocular region.
DESIGN: Retrospective, observational case series.
METHODS: The patients were divided into two groups: group A included those with sebaceous gland carcinoma with conjunctival intraepithelial (pagetoid) invasion, and group B included those with sebaceous gland carcinoma without conjunctival intraepithelial invasion. The demographic, clinical, and histopathologic features of sebaceous gland carcinoma were reviewed separately for each group. Ocular management results and systemic prognosis were reviewed.
RESULTS: Of the 25 patients, 18 (72%) were females and 7 (28%) were males. The mean age at diagnosis was 65 years (range, 17-90 years). There were 11 patients (44%) in group A, and 14 (56%) in group B. The most common symptom in group A was ocular irritation (45%), and in group B the most common symptom was eyelid lump (86%). The most common sign in group A was diffuse eyelid thickening (72%), and in group B the most common sign was a distinct eyelid mass (43%). Six patients (55%) in group A, compared with one patient (7%) in group B, had both upper and lower eyelid involvement. The most frequent location of tumor epicenter was the outer third of the eyelid in both groups: 37% in group A and 57% in group B. Histopathologic origin of tumor was multicentric in four patients (36%) of group A and six patients (50%) of group B. Before referral, local recurrence had been found in 4 of 12 patients (33%) who underwent surgical treatment elsewhere. After referral, local recurrence was detected in 1 patient (9%) in group A and in 2 patients (14%) in group B. Orbital exenteration was necessary in 4 patients (36%) in group A and in one patient (7%) in group B. Tumor-related metastases occurred in two patients (18%) in group A and in two patients (14%) in group B.
CONCLUSIONS: Sebaceous gland carcinoma with conjunctival intraepithelial (pagetoid) invasion has different clinical features compared with that without pagetoid invasion. Conjunctival intraepithelial (pagetoid) invasion carries a higher risk for orbital exenteration, but the risk of tumor-related metastases is similar in both groups.

Entities:  

Mesh:

Year:  2001        PMID: 11581065     DOI: 10.1016/s0161-6420(01)00719-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  22 in total

1.  Mitomycin C in sebaceous gland carcinoma with pagetoid spread.

Authors:  K Tumuluri; G Kourt; P Martin
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

2.  Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.

Authors:  Youn Joo Choi; Hyun Chul Jin; Min Joung Lee; Namju Kim; Ho-Kyung Choung; Sang In Khwarg
Journal:  Jpn J Ophthalmol       Date:  2014-04-25       Impact factor: 2.447

3.  CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.

Authors:  Tatsuya Yunoki; Tetsushi Hirano; Yoshiaki Tabuchi; Yukihiro Furusawa; Misako Torigoe; Takahiko Nakajima; Johji Imura; Atsushi Hayashi
Journal:  Int Ophthalmol       Date:  2019-09-30       Impact factor: 2.031

4.  Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.

Authors:  Yun Hsia; Ching-Yuan Yeh; Yi-Hsuan Wei; Lily-Wei Chen; Shu-Lang Liao
Journal:  Eye (Lond)       Date:  2019-05-31       Impact factor: 3.775

Review 5.  Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence?

Authors:  Pia R Mendoza; Hans E Grossniklaus
Journal:  Int Ophthalmol Clin       Date:  2015

6.  American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.

Authors:  Bita Esmaeli; Qasiem J Nasser; Hilda Cruz; Melissa Fellman; Carla L Warneke; Doina Ivan
Journal:  Ophthalmology       Date:  2012-02-11       Impact factor: 12.079

7.  Sebaceous Gland Carcinoma of Eyelid- A Tarnished Masquerade.

Authors:  Bijnya Birajita Panda; Sucheta Parija; Susanta Pujahari; Jyotiranjan Mallick
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 8.  [Differential diagnostics of sebaceous tumors].

Authors:  A Böer-Auer
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

9.  High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma.

Authors:  Thomas J Kandl; Oded Sagiv; Jonathan L Curry; Jing Ning; Junsheng Ma; Courtney W Hudgens; John Van Arnam; Jennifer A Wargo; Bita Esmaeli; Michael T Tetzlaff
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

10.  Clustering of sebaceous gland carcinoma, papillary thyroid carcinoma and breast cancer in a woman as a new cancer susceptibility disorder: a case report.

Authors:  Brian D Newman; Joseph F Maher; Jose S Subauste; Gabriel I Uwaifo; Steven A Bigler; Christian A Koch
Journal:  J Med Case Rep       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.